40.90USD-0.99%Mkt Cap: 2.17B USDP/E: —Last update: 2026-05-22
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap2.17B USD
Enterprise Value2.12B USD
Revenue (TTM)238.10M USD
Gross Profit167.35M USD
Net Income (TTM)-15.70M USD
Revenue/Share4.997 USD
Last Price40.90 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees622
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)56.72
PEG99.04
EV/EBITDA-991.01
EV/Revenue8.89
P/S9.23
P/B8.97
EPS (TTM)-0.64
EPS (Forward)0.73
52W Range
9.22087% of range45.83
52W High45.83 USD
52W Low9.220 USD
Profitability
Gross Margin74.31%
Oper. Margin-4.61%
EBITDA Margin-0.90%
Profit Margin-6.97%
ROE-12.19%
ROA-7.08%
Growth
Revenue Growth26.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF812.00K USD
CapEx (TTM)5.59M USD
FCF Margin7.68%
FCF Yield0.84%
Net Debt-80.96M USD
Net Debt/EBITDA37.92
Balance Sheet
Debt/Equity0.52
Current Ratio7.10
Quick Ratio4.99
Book Value/Sh4.606 USD
Cash/Share1.911 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 27, 2010
Pay DateFeb 12, 2010
Splits
Last Split105:100
Split DateJul 11, 1994
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)50.78 USD
Target Range48.00 USD – 55.00 USD
# Analysts9
Ownership
Shares Out.53.18M
Float51.90M
Insiders2.10%
Institutions94.69%
Short Interest
Short Ratio2.7d
Short % Float7.41%
Short % Out.6.40%
Shares Short3.40M
Short (prev mo.)3.50M
Technical
SMA 5036.83 (+11.0%)
SMA 20027.87 (+46.8%)
Beta1.17
S&P 52W Chg28.31%
Avg Vol (30d)1.08M
Avg Vol (10d)850.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—